A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.

NCT07407634 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

DRUG: Test drug XTYW007 capsules and placebo,Single dose group
DRUG: Test drug XTYW007 capsules and placebo,Food Impact Group
DRUG: Test drug XTYW007 capsules and placebo,Multiple dosing group

Sponsor

Xi'an Xintong Pharmaceutical Research Co.,Ltd.